Biogen Inc. BIIB said Wednesday it has appointed Dr. Jane Grogan as head of research, effective Oct. 2. Grogan was most recently chief scientific officer at Graphite Bio, a cell and gene editing company. She also spent 15 years at Genentech, where she held senior roles across immunology and immuno-oncology, covering research strategies and drug development across RA, Lupus, MS, IBD and cancer. Biogen’s stock has fallen 3.8% in the year to date, while the S&P 500 SPX has gained 17%.
…
